Boosters’ Omicron impact outlined in vaccination tool update GPs and patients can now generate personalised information on the risks and benefits associated with choosing whether or not to receive a booster shot.
Australia the first to approve Moderna vaccine in young children Kids aged 6–11 will soon be able to receive the Moderna Spikevax COVID vaccine, after it received provisional approval for use in this cohort.
Novavax rollout fast-tracked After months of delays, the rollout of Australia’s fourth COVID vaccine began over the weekend.
ATAGI releases clinical information for teen boosters Around 65% of teenagers aged 16 and over are now eligible to receive a COVID booster vaccine.
Doctors again voice opposition to pharmacy prescribing The decision to extend a UTI pharmacy prescribing pilot program has prompted a warning from the RACGP and Urological Society of Australia.
ATAGI rules on Novavax The long-awaited vaccine will be available from 21 February, but the RACGP has said general practice needs more support for the rollout.
Third COVID vaccine dose recommended for immunocompromised kids Severely immunocompromised children aged 5–11 should receive a third COVID vaccine as part of their primary course, ATAGI says.
Vaccination gap: Vulnerable communities left exposed as Omicron threatens Aboriginal and Torres Strait Islander COVID vaccination rates continue to lag the general population, with some areas still less than 50% fully vaccinated.
Ministers told ‘overwhelmed’ GPs need help Pressure from two major vaccine rollouts, the surge in Omicron cases, and ongoing community care is threatening the short-term viability of general practice.
In Practice: Valuable information for RACGP members The first edition for 2022 contains professional and clinical information directly relevant to general practice.